C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 7/06 (2006.01) C07K 7/08 (2006.01) C07K 14/745 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2382056
The invention relates to inhibiting human platelet aggregation, thrombosis and cell activation mediated by PAR1 with peptide analogs corresponding to those of Formula I and II, wherein Formula I is: Arg-Gly-Lys-Z4-Cys (SEQ ID NO: 43) wherein: Z4 is any naturally occurring amino acid, excluding cysteine; and wherein Formula II is: Arg-Gly-Asp-Z4-Cys (SEQ ID NO: 44) wherein: Z4 is any naturally occurring amino acid, excluding cysteine.
L'invention concerne l'inhibition de l'agrégation plaquettaire humaine, de la thrombose et de l'activation cellulaire induite par PAR1, au moyen d'analogues peptidiques représentés par les formules I et II. Formule I: Arg-Gly-Lys-Z¿4?-Cys (SEQ ID NO: 43), Z¿4? représentant n'importe quel acide aminé naturel à l'exception de la cystéine. Formule II: Arg-Gly-Asp-Z¿4?-Cys (SEQ ID NO: 44), Z¿4? représentant n'importe quel acide aminé naturel à l'exception de la cystéine.
Hasan Ahmed A. K.
Schmaier Alvin H.
Gowling Lafleur Henderson Llp
The Regents Of The University Of Michigan
Thromgen Inc.
LandOfFree
Peptide analogs as selective inhibitors of thrombin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide analogs as selective inhibitors of thrombin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide analogs as selective inhibitors of thrombin... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1415774